Cargando…

Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination

RATIONALE: Preeclampsia is a devastating medical complication of pregnancy which leads to maternal and fetal morbidity and mortality. While the etiology of preeclampsia is unclear, human and animal studies suggest that excessive circulating levels of soluble fms-like tyrosine-kinase-1 (sFlt-1), an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagmann, Henning, Bossung, Verena, Belaidi, Abdel Ali, Fridman, Alexander, Karumanchi, S. Ananth, Thadhani, Ravi, Schermer, Bernhard, Mallmann, Peter, Schwarz, Guenter, Benzing, Thomas, Brinkkoetter, Paul T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897409/ https://www.ncbi.nlm.nih.gov/pubmed/24465515 http://dx.doi.org/10.1371/journal.pone.0085258

Ejemplares similares

Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model
por: Venditti, Carolina C., et al.
Publicado: (2014)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
por: Moore, Kyle H., et al.
Publicado: (2020)

Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase
por: Oe, Yuji, et al.
Publicado: (2018)

Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
por: Davis, Sarah M., et al.
Publicado: (2022)

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
por: Saxena, Aditi R, et al.
Publicado: (2013)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
por: Matsui, Masaru, et al.
Publicado: (2022)

The Atypical Cyclin-Dependent Kinase 5 (Cdk5) Guards Podocytes from Apoptosis in Glomerular Disease While Being Dispensable for Podocyte Development
por: Mangold, Nicole, et al.
Publicado: (2021)

VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Hussein, Sama, et al.
Publicado: (2022)

Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model
por: Vogtmann, Rebekka, et al.
Publicado: (2021)

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
por: Ku, Ching-Hsin, et al.
Publicado: (2008)

sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo
por: Altiok, Eda I., et al.
Publicado: (2016)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
por: Wang, Na, et al.
Publicado: (2021)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Experimental Models to Study Podocyte Biology: Stock-Taking the Toolbox of Glomerular Research
por: Hagmann, Henning, et al.
Publicado: (2018)

Attenuation of VEGFR-2 Expression by sFlt-1 and Low Oxygen in Human Placenta
por: Nevo, Ori, et al.
Publicado: (2013)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
por: Souders, Colby A., et al.
Publicado: (2015)

In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy
por: Szalai, Gabor, et al.
Publicado: (2014)

Neuronal sFlt1 and Vegfaa determine venous sprouting and spinal cord vascularization
por: Wild, Raphael, et al.
Publicado: (2017)

Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1
por: Eslani, Medi, et al.
Publicado: (2017)

The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
por: Zhao, Guangxian, et al.
Publicado: (2017)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
por: Penka, Lukas, et al.
Publicado: (2020)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2020)

Correlation between 25-Hydroxyvitamin D, sFlt-1, PLGF, and Hypertension in Pregnancy
por: Wang, Wei, et al.
Publicado: (2021)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Nuzzo, Anna Maria, et al.
Publicado: (2021)

The sFlt-1/PlGF Ratio in Pregnant Patients Affected by COVID-19
por: Kosinska-Kaczynska, Katarzyna, et al.
Publicado: (2023)

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
por: Sá, Catherine Primo Nogueira de, et al.
Publicado: (2020)

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
por: Sasagawa, Tadashi, et al.
Publicado: (2020)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2007)

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia
por: Bian, Zheng, et al.
Publicado: (2015)

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK
por: Vatish, M., et al.
Publicado: (2016)

The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy
por: Zhai, Yaling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fie94vft3njdsrrep1jmd9ftjc